Brain Metastases in EGFR- and ALK-Positive NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation
J Thorac Oncol 2021 Aug 26;[EPub Ahead of Print], NJ Thomas, NJ Myall, F Sun, T Patil, R Mushtaq, C Yu, S Sinha, EL Pollom, S Nagpal, DR Camidge, CG Rusthoven, SE Braunstein, HA Wakelee, CE McCoachFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.